How many employees work at Sumitomo Pharma America?
Sumitomo Pharma America, Inc. has 2,385 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is -0.3%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
About Sumitomo Pharma America
We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here: bit.ly/3CozDLX
As of September 2025
Sumitomo Pharma America
workforce metrics
Headcount
2.4k
Avg. Salary
$177.9k
Tenure
4.6yr
Growth Rate
-0.3%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Employee Headcount
Interactive chart of Sumitomo Pharma America annual worldwide employee count from 2023 to 2025.
- Sumitomo Pharma America total number of employees in 2025 was 2,424.861, a 0.3% decline from 2024.
- Sumitomo Pharma America total number of employees in 2024 was 2,330.148, a 19.3% decline from 2023.
- Sumitomo Pharma America total number of employees in 2023 was 2,799.869, a 4.7% increase from 2022.
Would you like to see the latest employee headcount data?
Employee Geographic Breakdown
Would you like to see the latest employee geographic data?
Active Job Postings
Interactive chart of Sumitomo Pharma America annual active job postings from 2023 to 2025.
- Sumitomo Pharma America active job postings in 2025 was 190, a 21.6% increase from 2024.
- Sumitomo Pharma America active job postings in 2024 was 91, a 63.8% increase from 2023.
- Sumitomo Pharma America active job postings in 2023 was 47, a 100.5% decline from 2022.
Would you like to see the latest active job postings data?
Employee Sentiment
Sentiment Topics
Would you like to see the latest employee sentiment data?
